Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
Yu ZengNanhong LiWang LiuMingqing ZengJunfen ChengJian HuangPublished in: Journal of cancer research and clinical oncology (2020)
PLKs are relevant targets for NSCLC treatment, especially PLK1 and PLK4.